Poster Contest 2012

34 posters were presented at the BREACH symposium 2012 (Belgian HIV Prevention Summit)

Below you can find them in alphabetical order (based on the first author).

 

 

BREACH 2012 POSTER CONTEST AWARD WINNERS

 

Relative frequency and clinical charcteristics of acute or recent HIV infections among new patients in 2010 in one center in Belgium.

Kristien Wouters, Ilse Kint, Eric Florence, Annelies Van den Heuvel, Katrien Fransen, Olivier Koole, Lutgarde Lynen.

See poster ... (see also under "Lectures Symposium 2012").

 

"Evaluation safe sex zone." Gay businesses participate in the prevention effort.

Mark Sergeant.

See poster ...

 

 

OTHER POSTERS

 

Late presenters at the HIV/STI clinic in Antwerp, Belgium.

Apers L, Koole O, Manirankunda L, Lynen L, Florence E.

See poster ...

 

Sexually transmitted infections among HIV positive MSM prior to HCV infection.

Apers L, Vandenbruaene M, Van Esbroeck M, Crucitti T, Florence E.

See poster ...

 

In vitro evaluation of triazine non-nucleoside reverse transcriptase inhibitors (NNRTIs) as potential microbi-cides.

Ariën KK, Venkatraj M, Michiels J, Joossens J, Van der Veken P, Heeres J, Crucitti T, Lewi P, Augustyns K, Vanham G.

See poster ...

 

Two HIV-2 Env regions potentially involved in intracellular transport acts at two different moments during viral reproduction.

Bakouche N, de Sany P, Ruelle J.

See poster ...

 

Induction of high titers HIV-1 neutralizing antibodies against Tier 1 and Tier 2 viruses using a DNA prime heterologous protein trimer boost strategy in rabbits.

Bowles E, Uchtenhagen H, Heyndrickx L, LaBranche C, Jansson M, Achour A, Fomsgaard A, Montefiori D, Stewart-Jones G, Spetz AL.

See poster ...

 

Determinants of adherence in HIV patients: a pilot study.

Degroote S, Vogelaers D, Vermeir P, Mariman A, De Rick A, Van Der Gucht B, Van Wanzeele F, Pelgrom J, Moerman F, Vandijck D.

See poster ...

 

Determinants of quality of life in HIV patients: a pilot study.

Degroote S, Vogelaers D, Vermeir P, Mariman A, De Rick A, Van Der Gucht B, Van Wanzeele F, Pelgrom J, Moerman F, Vandijck D.

See poster ...

 

Enquête sur les conditions de vie des personnes vivant avec le VIH en Belgique francophone (Wallonie et Bruxelles 2010-2012). Présentation de quelques résultats préliminaires.

GRECOS (Groupe de Réflexion et de Communication sur la Séropositivité).

See poster ...

 

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization.

Heyndrickx L, Stewart-Jones G, Schuitemaker H, Bowles E, Buonaguro I, Jansson M, Grevstad B, Vinner L, Ramaswamy M, Biswas P, Scarlatti G, Vanham G, Fomsgaard A (NGIN Consortium).

See poster ...

 

The carbohydrate binding lectin Microvirin and its divalent form display potent anti-HIV-1 activity.

Huskens D, Kehr JC, Dittmann E, Schols D.

See poster ...

 

HIV in the dental practice. A case driven intervention in coopreation with a professional dentist association.

Koeck Ria.

See poster ...

 

Infections sexuellement transmissibles (IST) chez les patients infectés par le VIH et dépistage de VIH dans un centre IST.

Libois A, De Wit S, Delforge M, Semaille P, Aertsens F, Clumeck N.

See poster ...

 

Cellular sequence insertion in HIV-1 reverse transcriptase confers resistance to RTIs and partly compen-sates for replication deficits of RTI mutations.

Megens S, Vaira D, Dekeersmaeker N, Schrooten Y, Vandamme AM, Moutschen M, Van Laethem K.

See poster ...

 

Correlates and prevalence of co-receptor switch in ART naive HIV patients.

Mortier V, Staelens D, Schauvliege M, Vancoillie L, Vogelaers D, Plum J, Vandekerckhove L, Chalmet K, Verhofstede C.

See poster ...

 

Perfomance of the subtyping tools in the surveillance of the HIV-1 epidemic: comparison between the new Rega version 3 and six other automated tools to identify pure subtypes and circulating recombinant forms.

Pineda AC, Faria NR, Imbrechts S, Libin P, Deforche K, Abecasis AB, Gomez A, Camacho RJ, Oliveira T, Vandamme AM.

See poster ...

 

Results of 3 years outreach VCT for HVI/STI in gay venues in Antwerp, Belgium.

Platteau T, Wouters K, Nöstlinger C, Apers L, Florence E.

See poster ...

 

Transmission of primary resistance mutation K103N in a cluster of Belgian young patients from different risk groups.

Ruelle J, Ingels MG, Jnaoui K, Ausselet N, Sasse A, Verhofstede C, Goubau P (Belgian AIDS Reference Laboratories).

See Poster ...

 

Dissecting HIV-1 integration site selection using a LEDGF/p75 knockoit cell line.

Schrijvers R, Vets S, Demeulemeester J, De Rijck J, Bushman FD, Gijsbers R, Debyser Z.

See poster ...

 

M48U1 CD4 mimetic has a memory effect on cell-associated HIV-1 by severely reducing virion infectivity through gp120 shedding.

Selhorst P, Grupping K, Tong T, Crooks ET, Martin L, Vanham G, Binley JM, Ariën KK.

See poster ...

 

"Live positive." Evaluation of a campaign on the high prevalence of HIV and its consequences for MSM in Flanders.

Sergeant M.

See poster ...

 

"Testen? Gewoon doen!" A campaign urging MSM to test regularly on HIV and STIs.

Sergeant M.

See poster ...

 

Acquired hemophilia A: an uncommon cause of bleeding in a HIV-infected patient.

Serroukh Y, Demeester R, Godefroid C, Cauchie P, Piagnerelli M, Biston P, Legrand JC.

See poster ...

 

A Bayesian network approach to study host and viral genetic correlates of HIV-1 disease progression.

Snoek J, Casado C, Colombo S, Rauch A, Garcia S, Martinez R, Theys K, Khouri R, Günthard HF, Telenti A, Lopez-Galindez C, Vandamme AM.

See poster ...

 

Changing selection rates of resistance mutation K65R in antiretroviral-experienced HIV-1 infected patients.

Theys K, Snoeck J, Vercauteren J, Abecasis AB, Vandamme AM, Camacho R.

See poster ...

 

Evolution of the knowledge in HIV transmission from 1997 to 2008 among the young people aged 15-24 yrs: data from the Belgian Health Interview Survey.

Van Beckhoven D, Verbrugge R, Charafeddine R, Sasse A.

See poster ...

 

HIV testing in Europe: opportunities in primary care.

Van der Veken A, Deblonde J, Callens S.

See poster ...

 

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1 infected patients.

Van Gulck E, Vlieghe E, Vekemans M, Van Tendeloo VFI, Van De Velde A, Smits E, Anguille S, Cools N, Goossens H, Mertens L, De Haes W, Wong J, Florence E, Vanham G, Berneman ZW.

See poster ...

 

Knowledge about HIV transmission from the Belgian Health Interview Survey 2008.

Verbrugge R, Van Beckhoven D, Charafeddine R, Sasse A.

See poster ...

 

The demise of multidrug resistant HIV-1.

Vercauteren J, Theys K, Carvalho AP, Valadas E, Duque LM, Teofilo E, Faria T, Faria D, Vera J, Aguas MJ, Peres S, Mansinho K, Vandamme AM, Camacho R (Portuguese HIV-1 Resistance Group).

See poster ...

 

Using conventional HIV tests for HIV diagnosis on oral fluid specimens.

Vermoesen T, Beelaert G, Menten J, Hutse V, Wouters K, Platteau T, Florence E, Fransen K.

See poster ...

 

Registration of HIV-risk factors in the electronic medical record (EMR): what do GPs in Flanders prefer?

Vos J, Deblonde J, Van den Eynde S, Deveugele M, Avonts D.

See poster ...